Summary
Definição
História e exame físico
Principais fatores diagnósticos
- debilidad unilateral o parálisis en la cara, el brazo o la pierna
- pérdida sensorial (entumecimiento)
- disfasia
- disartría
- alteración visual
- fotofobia
- cefalea
- ataxia
- Factores de riesgo
Outros fatores diagnósticos
- vértigo
- náuseas y vómitos
- disminución del nivel de conciencia/coma
- confusión
- paresia de la mirada
Fatores de risco
- hipertensión
- edad avanzada
- sexo masculino
- Asiático, negro y/o latino/hispano
- consumo excesivo de alcohol
- simpaticomiméticos ilegales
- antecedentes familiares de hemorragia intracerebral
- hemofilia
- angiopatía amiloide cerebral
- anemia falciforme
- mutaciones autosómicas dominantes en el gen COL4A1
- telangiectasia hemorrágica hereditaria
- mutaciones autosómicas dominantes en el gen KRIT1, el gen CCM2 o el gen PDCD10
- anticoagulación
- malformaciones vasculares
- enfermedad de Moyamoya
- embarazo
- tabaquismo
- antiinflamatorios no esteroideos (AINE)
- apnea obstructiva del sueño
- diabetes mellitus
- simpaticomiméticos
- vasculitis cerebral
- trombocitopenia
- leucemia
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- tomografía computarizada (TC) de cabeza sin contraste.
- glucosa sérica
- electrolitos séricos
- urea y creatinina séricas
- pruebas de función hepática
- hemograma completo (HC)
- prueba de coagulación
- electrocardiograma (ECG)
Investigações a serem consideradas
- cribado toxicológico en suero
- Angiografía por TC (ATC) o angiografía por resonancia magnética (ARM) de la cabeza
- Venografía por tomografía computarizada (TC) o venografía por resonancia magnética (VRM) de la cabeza
- Angiografía cerebral intraarterial
Algoritmo de tratamento
sospecha de hemorragia intracerebral
hemorragia intracerebral confirmada
Colaboradores
Consultores especialistas
Matthew Jones, MD, FRCP
Consultant Neurologist
Manchester Centre for Clinical Neurosciences
Northern Care Alliance
Honorary Senior Lecturer
University of Manchester
Manchester
UK
Declarações
MJ is the chair of the Association of British Neurologists Education Committee (unpaid position). MJ is a faculty member of an MRCP revision course. MJ has received honoraria from Eisai for educational talks.
Acknowledgements
BMJ Best Practice would like to gratefully acknowledge the previous expert contributors, whose work has been retained in parts of the content:
Fernando D. Goldenberg, MD
Clinical Associate of Neurology
Medical Director, Neuroscience ICU
Director, Neurocritical Care Education
Co-Director, Stroke Center
University of Chicago
Chicago
IL
Raisa C. Martinez, MD
Neurocritical Care Fellow
Department of Neurology
University of Chicago
Chicago
IL
Declarações
FDG and RCM declare that they have no competing interests.
Revisores
David Werring, FRCP, PhD, FESO
Professor of Clinical Neurology
Head of Research Department, Brain Repair and Rehabilitation
UCL Institute of Neurology
Honorary Consultant Neurologist
National Hospital for Neurology and Neurosurgery
University College Hospitals NHS Foundation Trust
North Thames Clinical Research Specialty Lead for Stroke
NIHR Clinical Research Network
London
UK
Declarações
DW has received honoraria (speaking) from Bayer 2016, 2017, 2018 (talks or debates on intracerebral haemorrhage, atrial fibrillation, dementia) and honoraria (chairing) from Portola and Bayer 2019. DW has received consultancy fees from Bayer (2017; embolic stroke of undetermined source), JFB consulting (2018; PCSK9 inhibitors in stroke), Alnylam (2019; cerebral amyloid angiopathy), Portola (2019, 2020; andexanet alpha). JW was UCL Principle Investigator for NIHR clinical trials NAVIGATE-ESUS (Bayer, 2016-19), B2341002 (Pfizer 2014-2016), Action-2 (Biogen, 2016-19); Chief Investigator for OPTIMAS; steering committee and co-investigator for RESTART, TICH-2.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2022 Jul;53(7):e282-361.Texto completo Resumo
Intercollegiate Stroke Working Party. National clinical guideline for stroke for the UK and Ireland. May 2023 [internet publication].Texto completo
National Institute for Health and Care Excellence. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. Apr 2022 [internet publication].Texto completo
Royal College of Physicians. National Clinical Guideline for Stroke. Oct 2016 [internet publication].Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

Diagnósticos diferenciais
- Accidente cerebrovascular isquémico
- Encefalopatía hipertensiva
- Hipoglucemia
Mais Diagnósticos diferenciaisDiretrizes
- National clinical guideline for stroke for the United Kingdom and Ireland
- Stroke and transient ischaemic attack in over 16s: diagnosis and initial management
Mais DiretrizesCalculadoras
Escala de accidente cerebrovascular del NIH
Escala de Coma de Glasgow
Mais CalculadorasVideos
Demostración animada de venopunción y flebotomía
Demostración animada de como realizar un electrocardiograma (ECG)
Mais vídeosFolhetos informativos para os pacientes
Accidente cerebrovascular: tratamiento
preguntas para formularle al médico si ha sufrido un accidente cerebrovascular
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal